In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 3080-99-7, name is 3,4-Dihydro-2H-benzo[b][1,4]thiazine, introducing its new discovery. Quality Control of 3,4-Dihydro-2H-benzo[b][1,4]thiazine
SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA CONVERTING ENZYME (TACE)
The present application describes novel spiro-cyclic beta-amino acid derivatives of formula I: or pharmaceutically acceptable salt forms thereof, wherein ring B is a 3-13 membered carbocycle or heterocycle, ring C forms a 3-11 membered spiro-carbocycle or spiro-heterocycleon ring B, and the other variables are defined in the present specification, which are useful as as matrix metalloproteinases (MMP), TNF-alpha converting enzyme (TACE), and/or aggrecanase inhibitors.
Because enzymes can increase reaction rates by enormous factors and tend to be very specific, Quality Control of 3,4-Dihydro-2H-benzo[b][1,4]thiazine, typically producing only a single product in quantitative yield, they are the focus of active research.you can also check out more blogs about Quality Control of 3,4-Dihydro-2H-benzo[b][1,4]thiazine
Reference£º
Thiazine – an overview | ScienceDirect Topics,
Thiazine | C4H5NS – PubChem